Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in Bacteria

References

1. Adams S. E., Dawson K. M., Gull K., Kingsman S. M., Kingsman A. J. 1987; The expression of hybrid HIV :Ty virus-like particles in yeast. Nature; London: 32968–70
   [Google Scholar]
2. Argos P., Fuller S. D. 1988; A model for the hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO Journal 7:819–824
   [Google Scholar]
3. Burke K. L., Dunn G., Ferguson M., Minor P. D., Almond J. W. 1988; Antigen chimeras of poliovirus as potential new vaccines. Nature; London: 33281–82
   [Google Scholar]
4. Charbit A., Van Der Werf S., Mimic V., Boulain J. C., Girard M., Hofnung M. 1988; Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunisation results. Annals de L’lnstitut Pasteur/Microbiologie 139:45–58
   [Google Scholar]
5. Clarke B. E., Newton S. E., Carroll A. R., Francis M. J., Appleyard G., Syred A., Highfield P., Rowlands D. J., Brown F. 1987; Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature; London: 330381–384
   [Google Scholar]
6. De Boer H. A., Comstock L. J., Yansura D. G., Heynecker H. L. 1982; Construction of a tandem trp-lacpromoter and a hybrid trp-lacpromoter for efficient and controlled expression of the human growth hormone gene in E. coli. In Promoter Structure and Function pp 462–481 Rodriguez R. L., Chamberlain M. J. Edited by New York: Praeger Publishing;
   [Google Scholar]
7. Delpeyroux F., Chenciner N., Lim A., Malpiece Y., Blondel B., Crainic R., Van Der Werf S., Streeck R. E. 1986; A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science 233:472–475
   [Google Scholar]
8. Delpeyroux F., Peillon N., Blondel B., Crainic R., Streeck R. E. 1988; Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles. Journal of Virology 62:1836–1839
   [Google Scholar]
9. Dintzis R. Z., Middleton M. H., Dintzis H. M. 1983; Studies of the immunogenicity and tolerogenicity of T-independent antigens. Journal of Immunology 131:2196–2203
   [Google Scholar]
10. Francis M. J., Hastings G. Z., Sangar D. V., Clark R. P., Syred A., Clarke B. E., Rowlands D. J., Brown F. 1987; A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. Journal of General Virology 68:2687–2691
    [Google Scholar]
11. Francis M. J., Hastings G. Z., Brown A. L., Grace K. G., Rowlands D. J., Brown F., Clarke B. E. 1990; Immunological properties of hepatitis B core antigen fusion proteins. Proceedings of the National Academy of Sciences U.S.A: in press
    [Google Scholar]
12. Holmes D. S., Quigley M. 1981; A rapid boiling method for the preparation of bacterial plasmids. Analytical Biochemistry 114:193–197
    [Google Scholar]
13. Horaud F., Crainic R., Van Der Werf S., Blondel B., Wichowski C., Akacem O., Bruneau P., Couillin P., Siffert O., Girard M. 1987; Identification and characterisation of a continuous neutralization epitope (C3) present on type 1 poliovirus. Progress in Medical Virology 34:129–155
    [Google Scholar]
14. Houghten R. A. 1985; General method for the rapid synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proceedings of the National Academy of Sciences U.S.A.: 825131–5135
    [Google Scholar]
15. Kitamura N., Semler B. L., Rothberg M. G., Larsen G. R., Adler C. J., Dorner A. H., Emini E. A., Hanecak R., Lee J. J., Van Der Werf S., Anderson C. W., Wimmer E. 1981; Primary structure, gene organisation and polypeptide expression of poliovirus RNA. Nature; London: 291547–553
    [Google Scholar]
16. Krausslich H. G., Schneider H., Zybarth G., Carter C. A., Wimmer E. 1988; Processing of in vitrosynthesised gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. Journal of Virology 62:4393–4397
    [Google Scholar]
17. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
18. MacKay P., Lees J., Murray K. 1981; The conversion of hepatitis B core antigen synthesised in E. coliinto e antigen. Journal of Medical Virology 8:237–243
    [Google Scholar]
19. McLachlan A., Milich D. R., Raney A. K., Riggs M. G., Hughes J. L., Sorge J., Chisari F. V. 1987; Expression of hepatitis B virus surface and core antigens: influence of pre-S and precore sequences. Journal of Virology 61:683–692
    [Google Scholar]
20. Martin A., Wychowski C., Couderc T., Crainic R., Hogle J., Girard M. 1988; Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO Journal 7:2839–2847
    [Google Scholar]
21. Merrifield R. B. 1963; Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society 85:2149–2154
    [Google Scholar]
22. Messing J. 1979; A multipurpose cloning system based on singlestranded DNA bacteriophage M13. Recombinant DNA Technical Bulletin 2:43
    [Google Scholar]
23. Milich D. R., McLachlan A. 1986; The nucleocapsid of the hepatitis B virus is both a T cell-independent and a T cell-dependent antigen. Science 234:1398–1401
    [Google Scholar]
24. Milich D. R., McLachlan A., Moriarty A., Thornton G. 1987; Immune response to hepatitis B virus core antigen (HBcAg): localisation of T cell recognition sites within HBsAg/HBeAg. Journal of Immunology 139:1223–1231
    [Google Scholar]
25. Milich D. R., McLachlan A., Stahl S., Wingfield P., Thornton G. B., Hughes J. L., Jones J. E. 1988; Comparative immunogenicity of hepatitis B virus core and e antigens. Journal of Immunology 141:3617–3624
    [Google Scholar]
26. Miller R. H. 1987; Proteolytic self-cleavage of hepatitis B virus core protein may generate serum e antigen. Science 236:722–725
    [Google Scholar]
27. Nassal M., Galle P. R., Schaller H. 1989; Proteaselike sequence in hepatitis B virus core antigen is not required for e antigen generation and may not be part of an aspartic acid-type protease. Journal of Virology 63:2598–2604
    [Google Scholar]
28. Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genba Y., Nakano Y., Imura N. 1982; Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proceedings of the National Academy of Sciences U.S.A.: 795793–5797
    [Google Scholar]
29. Ou J. H., Laub O., Rutter W. J. 1986; Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of e antigen. Proceedings of the National Academy of Sciences U.S.A.: 831578–1582
    [Google Scholar]
30. Pasek M., Goto T., Gilbert W., Zink B., Schaller H., Mackay P., Leadbetter G., Murray K. 1979; Hepatitis B virus genes and their expression in E. coli. Nature; London: 282575–579
    [Google Scholar]
31. Racaniello V. R., Baltimore D. 1981; Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proceedings of the National Academy of Sciences U.S.A.: 784887–4891
    [Google Scholar]
32. Roossinck M. J., Jameel S., Loukin S. H., Siddiqui A. 1986; Expression of hepatitis B viral core region in mammalian cells. Molecular and Cellular Biology 6:1393–1400
    [Google Scholar]
33. Skern T., Sommergruber W., Blaas D., Gruendler P., Fraun-Dorfer F., Pieler C., Fogy I., Kuechler E. 1985; Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Research 13:2111–2116
    [Google Scholar]
34. Skern T., Neubauer C., Frasel L., Gründler L., Sommer-Gruber W., Zorn M., Kuechler E., Blaas D. 1987; A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2. Journal of General Virology 68:315–323
    [Google Scholar]
35. Stahl S., Murray K. 1989; Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proceedings of the National Academy of Sciences U.S.A.: 866283–6287
    [Google Scholar]
36. Stahl S., MacKay P., Magazin M., Bruce S. A., Murray K. 1982; Hepatitis B core antigen: synthesis in E. coliand application in diagnosis. Proceedings of the National Academy of Sciences U.S.A.: 791606–1610
    [Google Scholar]
37. Stewart M. A., Warnock M., Wheeler A., Wilkie N., Mullins J. I., Onions D. E., Neil J. C. 1986; Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. Journal of Virology 58:825–834
    [Google Scholar]
38. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences U.S.A.: 764350–4354
    [Google Scholar]
39. Uy A., Bruss V., Gerlich W. H., Kochel H. G., Thomson R. 1986; Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. Virology 155:89–96
    [Google Scholar]
40. Valenzuela P., Coit D., Medina-Selby A., Kuo C. H., Vannest G., Burke R. L., Urdea M. S., Graves P. V. 1985; Antigen engineering in yeast: synthesis and assembly of hybrid hepatitis B surface antigen-herpes simplex 1 gD particles. Bio/Technology 3:323–326
    [Google Scholar]
41. Voller A., Bartlett A., Bidwell D. E., Clark M. F., Adams A. N. 1976; The detection of viruses by enzyme-linked immunosorbent assay (ELISA). Journal of General Virology 33:165–167
    [Google Scholar]